MKULQ — Molekule Balance Sheet
0.000.00%
- $0.01m
 - $30.91m
 - $0.23m
 
Annual balance sheet for Molekule, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st  | 2020 December 31st  | 2021 December 31st  | 2022 December 31st  | |
|---|---|---|---|---|
| Period Length: | — | — | — | — | 
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | 
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.001 | 2.33 | 19.6 | 22.1 | 
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0 | 0.101 | 0.177 | 0.036 | 
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Current Assets | 0.001 | 2.74 | 21.6 | 24.8 | 
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0 | 0.455 | 2.12 | 3.73 | 
| Net Goodwill | ||||
| Other Long Term Assets | ||||
| Total Assets | 0.001 | 3.19 | 23.7 | 29.2 | 
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.231 | 0.665 | 1.51 | 4.56 | 
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 0.231 | 0.665 | 2.01 | 9.46 | 
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | -0.231 | 2.53 | 21.7 | 19.7 | 
| Total Liabilities & Shareholders' Equity | 0.001 | 3.19 | 23.7 | 29.2 | 
| Total Common Shares Outstanding |